According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ9.96. In 2022 the company made an earnings per share (EPS) of -ยฃ9.96 an increase over its 2021 EPS that were of -ยฃ13.97.